Project Details
| Short title | ALK201-01 |
|---|---|
| Status | Finished |
| Effective start/end date | 18/12/24 → 24/09/26 |
CTU: A First-in-Human, Open-Label, Multi-Center Phase I/II Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Antitumor Activity of ALK201 for Injection in Adult Participants with Advanced Solid Tumors
- Parsonson, Andrew (Primary Chief Investigator)
- Quinlan, Gabriel (Clinical Trial Unit Staff)
- Armstrong, Emilia (Clinical Trial Unit Staff)
- Chapman, Nicola (Clinical Trial Unit Staff)
- Garcia, Michelle (Clinical Trial Unit Staff)
- Martin, Lewis (Clinical Trial Unit Staff)
Project: Research